Key Trends in Pharma Packaging
pharmatechoutlook

Pharma Tech Outlook: Pharma Tech Magazine

Key Trends in Pharma Packaging

Dylan Adkins, Manager IT, Materials and Packaging, Novo Nordisk

Dylan Adkins, Manager IT, Materials and Packaging, Novo Nordisk

In the pharma industry, the environment's safety has become as important as patient safety. 2020 has witnessed increased demand for sustainable packaging.

So far, 2020 has been a disruptive year for the pharmaceutical industry. It has faced many challenges, including delivering new product types, drug supply, and meeting market demands, to name a few. These challenges have helped the pharma industry evolve with time, ensuring patient protections and reaping benefits.

Let us look at some pharma packaging trends in 2020:

Child-Resistant Packaging Design

The CRP market's growth increased as many brands look to deliver the safest and most commercially feasible option.

Ziplock packages have recently become very popular for creating a lightweight and compact way of securing traditional and cannabis-based medicine.

Ziplock packaging is a single-entry design that needs mature dexterity in order to slide a zipper open to access the materials inside the package. Many designs even considered adding a flap that covers the zipper when the bag is closed, masking the entry point as an additional security layer. Packaging manufacturers also label child-resistant packaging clearly for consumers.

Wearable Tech

Surveys suggest that more than 80 percent of people are willing to wear wearable technology. It has been a major focus in 2020 as people are looking for ways to reduce the budget and burden on healthcare gadgets. The development of wearable tech would make it possible to get treatment outside of hospitals and into people's homes. "Wearable injections" have already become popular, allowing people more active involvement in their healthcare.

The next generation of pre-filled syringes would give patients stress-free and safe drug delivery without the requirement for clinical monitoring. This, in turn, decreases the number of expensive intravenous (IV) infusions and increases adherence, facilitating larger dose delivery as well as minimizing the risk of degradation.

Wearable devices are also changing the way clinical trials are managed. It works as a personal assistant to the user, monitoring their health status, and alerting them about abnormal conditions.

Ensuring the Environment's Safety

In the pharma industry, the environment's safety has become as important as patient safety. 2020 has witnessed increased demand for sustainable packaging. Packaging is the key area to reduce waste. Hence, the rising pressure on pharma has compelled it to change practices in order to reduce waste generation and stop global warming.

See also: Top Contract Packaging Consulting/Service Companies

Weekly Brief

Read Also

Late Pack Customization: the Way to Optimize Pharma Supply Chain

Late Pack Customization: the Way to Optimize Pharma Supply Chain

Tomasz Nawrocki, Pharmaceutical Supply Chain Service Department Director/ CEO Synoptis Industrial, Grupa NEUCA
What the New EMA Draft

What the New EMA Draft "Guideline on Computerized Systems and Electronic Data" Means to Your Systems

Cathlin Shapiro, Parexel, Director, Technology Quality Assurance
How Contract Research Organisations Can Help the Pharma Companies

How Contract Research Organisations Can Help the Pharma Companies

Skye Fitzgerald, Data Analytics Manager, Jazz Pharmaceuticals
Why are Contract Research Organizations Significant in the Pharma Industry?

Why are Contract Research Organizations Significant in the Pharma Industry?

Willie Martin, Director, Discovery Process, Alkermes
How can Manufacturing Companies Keep Pace with the Shifting Trends of Oncology Drug Development

How can Manufacturing Companies Keep Pace with the Shifting Trends of Oncology Drug Development

Stewart Campbell, VP & General Manager at West Pharmaceutical & Li Chen, VP & General Manager at West Pharmaceutical
Optimizing Alkermes' R&D Model for Success

Optimizing Alkermes' R&D Model for Success

Craig Hopkinson, M.D., CMO and Executive Vice President, Research and Development, Alkermes